• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国抗逆转录病毒治疗概述:进展与挑战。

Overview of antiretroviral treatment in China: advancement and challenges.

机构信息

Department of Infectious Diseases, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.

出版信息

Chin Med J (Engl). 2011 Feb;124(3):440-4.

PMID:21362348
Abstract

As the severity of the HIV epidemic in China grew, National Free Antiretroviral Treatment (ART) Program was announced since 2003. Even though there still were many difficulties, China had obtained great achievements in fighting against HIV. Over 52 000 adult patients had received first-line HAART thus far and the mortality of AIDS in China decreased significantly. This paper presents an overview of the HIV/AIDS epidemic in China; the status of national free ART program, the difficulties suffered and the achievements made since the initiation of program and the challenges ahead for continued progress for China. This paper also provides suggestions to overcome these challenges.

摘要

随着中国艾滋病疫情的严重程度加剧,自 2003 年起开始实施国家免费抗逆转录病毒治疗(ART)项目。尽管仍面临诸多困难,但中国在抗击艾滋病方面取得了巨大成就。迄今为止,已有超过 52000 名成年患者接受了一线抗逆转录病毒联合疗法,中国艾滋病的死亡率显著下降。本文概述了中国的艾滋病疫情;国家免费 ART 项目的现状、项目启动以来所面临的困难和取得的成就,以及中国继续取得进展所面临的挑战。本文还提出了克服这些挑战的建议。

相似文献

1
Overview of antiretroviral treatment in China: advancement and challenges.中国抗逆转录病毒治疗概述:进展与挑战。
Chin Med J (Engl). 2011 Feb;124(3):440-4.
2
Current progress of China's free ART program.中国免费抗逆转录病毒治疗项目的当前进展。
Cell Res. 2005 Nov-Dec;15(11-12):877-82. doi: 10.1038/sj.cr.7290362.
3
The Chinese free antiretroviral treatment program: challenges and responses.中国免费抗逆转录病毒治疗项目:挑战与应对措施
AIDS. 2007 Dec;21 Suppl 8:S143-8. doi: 10.1097/01.aids.0000304710.10036.2b.
4
Progress of the National Pediatric Free Antiretroviral Therapy program in China.中国国家儿童免费抗逆转录病毒治疗项目进展
AIDS Care. 2010 Oct;22(10):1182-8. doi: 10.1080/09540121003615129.
5
Scale-up of national antiretroviral therapy programs: progress and challenges in the Asia Pacific region.国家抗逆转录病毒治疗方案的扩展:亚太地区的进展和挑战。
AIDS. 2010 Sep;24 Suppl 3:S62-71. doi: 10.1097/01.aids.0000390091.45435.ea.
6
[The introduction of antiretroviral therapy in Malawi].[马拉维抗逆转录病毒疗法的引入]
Ned Tijdschr Geneeskd. 2006 Dec 16;150(50):2774-8.
7
Antiretroviral therapy: a primer for dermatologists.抗逆转录病毒疗法:皮肤科医生入门指南。
Dermatol Clin. 2006 Oct;24(4):537-47, vii. doi: 10.1016/j.det.2006.06.012.
8
High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda.卢旺达接受含司他夫定的一线抗逆转录病毒治疗方案的患者中脂肪萎缩的高患病率。
Trans R Soc Trop Med Hyg. 2007 Aug;101(8):793-8. doi: 10.1016/j.trstmh.2007.02.020. Epub 2007 Apr 30.
9
Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.利用早期预警指标监测中国的 HIV 耐药性:2008 年试点调查结果。
Clin Infect Dis. 2012 May;54 Suppl 4:S300-2. doi: 10.1093/cid/cir1018.
10
World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.世界卫生组织开展调查,以监测哨点抗逆转录病毒治疗点的艾滋病毒耐药性预防情况及相关因素。
Antivir Ther. 2008;13 Suppl 2:15-23.

引用本文的文献

1
Retrospective Study on Genetic Diversity and Drug Resistance among People Living with HIV at an AIDS Clinic in Beijing.北京某艾滋病诊所艾滋病毒感染者的基因多样性与耐药性回顾性研究
Pharmaceuticals (Basel). 2024 Jan 16;17(1):115. doi: 10.3390/ph17010115.
2
Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China.中国接受抗逆转录病毒治疗的 HIV 感染者低水平耐药病毒血症对 CD4 细胞计数的影响。
BMC Infect Dis. 2022 May 4;22(1):426. doi: 10.1186/s12879-022-07417-z.
3
A Real-world Evidence-based Management of HIV by Differential Duration HAART Treatment and its Association with Incidence of Oral Lesions.
基于真实世界证据的 HIV 差异化时长 HAART 治疗管理及其与口腔病变发生率的关联。
Curr HIV Res. 2022;20(1):91-99. doi: 10.2174/1570162X20666211227154558.
4
Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China.中国西南地区一个高毒品使用地区的 HIV 患者的预处理 HIV 耐药性调查和遗传传播网络分析。
Curr HIV Res. 2019;17(6):441-451. doi: 10.2174/1570162X17666191128101426.
5
Drug resistance evolution in patients with human immunodeficiency virus-1 under long-term antiretroviral treatment-failure in Yunnan Province, China.中国云南省长期抗逆转录病毒治疗失败的人类免疫缺陷病毒-1 感染者中的耐药性演变。
Virol J. 2019 Jan 8;16(1):5. doi: 10.1186/s12985-018-1112-6.
6
Task shifting of HIV/AIDS case management to Community Health Service Centers in urban China: a qualitative policy analysis.中国城市地区将艾滋病病例管理工作转移至社区卫生服务中心:一项定性政策分析
BMC Health Serv Res. 2015 Jul 2;15:253. doi: 10.1186/s12913-015-0924-y.
7
In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors.体外筛选对逆转录酶抑制剂耐药的HIV-1 CRF08_BC变异株。
AIDS Res Hum Retroviruses. 2015 Feb;31(2):260-70. doi: 10.1089/AID.2013.0211. Epub 2015 Jan 8.
8
Prevalence and mutation patterns of HIV drug resistance from 2010 to 2011 among ART-failure individuals in the Yunnan Province, China.2010 年至 2011 年期间中国云南省抗逆转录病毒治疗失败个体中 HIV 耐药性的流行情况和突变模式。
PLoS One. 2013 Aug 29;8(8):e72630. doi: 10.1371/journal.pone.0072630. eCollection 2013.
9
Treatment of acquired immunodeficiency syndrome with Chinese medicine in China: opportunity, advancement and challenges.中国中医药治疗获得性免疫缺陷综合征:机遇、进展与挑战。
Chin J Integr Med. 2013 Aug;19(8):563-7. doi: 10.1007/s11655-013-1552-1. Epub 2013 Jul 29.
10
Editorial commentary: China, HIV, and syphilis among men who have sex with men: an urgent call to action.编辑评论:中国男男性行为者中的艾滋病病毒与梅毒——紧急行动呼吁
Clin Infect Dis. 2013 Jul;57(2):310-3. doi: 10.1093/cid/cit213. Epub 2013 Apr 11.